| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |